Outsource API manufacturing to India for lower costs, GMP-compliant quality, scalable production, and faster time-to-market for pharma companies.
QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...
DUBLIN, May 10, 2021 /PRNewswire/ -- The "Global Active Pharmaceutical Ingredient Market (2020-2025) by Type, Molecule, Product Type, Formulation Type, Manufacturing Type, Synthesis Type, Drug Type, ...
AbbVie has announced plans to invest $380m to construct two new active pharmaceutical ingredient (API) manufacturing ...
−CDMO with a Six Decades-Long Reputation for Quality and Service Doubles Its Capacity to Take on New Development Projects− MORTON GROVE, Ill.--(BUSINESS WIRE)--Regis Technologies, Inc. today announced ...
Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...
AbbVie on Monday said it would invest $380 million to build two new active pharmaceutical ingredient manufacturing facilities ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results